Waukesha, Wisc. GE Healthcare has introduced a new ultrasound imaging system with early diagnostic tools for womens healthcare. This new technology, called the Voluson E8, paves the way for the future of advanced volume ultrasound and image quality, enabling GE to continue its leadership role in consistently delivering clinically relevant technologies that transform healthcare.

The Voluson E8 is the next generation of GEs Voluson ultrasound platform, and includes a number of new tools to help improve clinical workflow, including SonoVCAD (Sonography based Volume Computer Aided Diagnosis), a new automated imaging tool that improves workflow by making it easier to acquire volume images of the fetal heart. This GE-exclusive technology makes a difficult exam much easier by streamlining the acquisition of volumetric images of the fetal heart. This proprietary technology displays all of the 2-D planes, which complies with the recommended standard screening exam of the fetal heart, as outlined by the American Institute of Ultrasound in Medicine (AIUM), the American College of Obstetrics and Gynecology (ACOG), the American College of Radiology (ACR) and the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). It includes identification of the 4-chamber, left outflow tract and right outflow tract view of the fetal heart.

SonoVCAD introduces standardization into ultrasound imaging and helps to reduce the risk of operator exam misinterpretation. By simplifying the technical aspects associated with a fetal ultrasound exam, the detection of fetal heart abnormalities should also be enhanced, said Dr. Alfred Abuhamad, professor and chair of the department of OB/GYN at Eastern Virginia Medical Center in Norfolk, Va.


Other new tools available on the Voluson E8 include:

* A revolutionary new high-resolution 4-D transvaginal probe that helps clinicians see and detect fetal abnormalities earlier than ever before, while also showing promise for improving diagnostic confidence in complex GYN exams, such as early pathology diagnosis. This wide field of view and volume-scanning angle gather volumetric information on subtle anatomic structures. The 4-D transvaginal probe has the potential to dramatically improve our ability to discover fetal heart defects earlier, said Dr. Greggory DeVore, director of the Fetal Diagnostic Center in Pasadena, Calif.

* The new matrix array volume probe that improves image clarity for volume imaging, and provides better visualization for 2-D and multiplanar imaging with increased spatial resolution.

More Industry Headlines